# Psychedelics Surge: Market Madness Unleashed! Newsy: Bud Fox's 3 Controversial Stocks of the Day Published: 2026-04-20T14:00:00.199Z Source: https://newsyai.com/edition/3e92a5ad-a8f7-4dd5-af8c-455153ac8e38 Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md --- # Psychedelic Shroomnado: ENVB Nukes +130%, CMND Cockrocket +57%, PASG FDA Foreskin Flop -23%! **Premarket psychedelic circlejerk exploding**—**Dow futures 49,653 +0.02%**[[1]](https://www.cnn.com/markets/premarkets), **S&P 7,149 -0.16%**[[1]](https://www.cnn.com/markets/premarkets), **Nasdaq 26,752 -0.27%**[[1]](https://www.cnn.com/markets/premarkets); **WTI crude $85.92 +4.03%** oil's getting a rimjob from supply jitters! [[1]](https://www.cnn.com/markets/premarkets) Degen drug den: **ENVB** funding-fueled frenzy, **CMND** trial tease throbbing, **PASG** regulatory rectum-ream—bagholders barfing while shamans squeeze the serotonin sausage! [[2]](https://stockanalysis.com/markets/premarket/gainers/)[[3]](https://stockanalysis.com/markets/premarket/losers/) --- ## 1) Enveric Biosciences (ENVB): “Neuroplastogen Nutbuster” vs “Dilution Dickdrain Disaster” **Why it’s loud** **ENVB** detonating **+130% to ~$4.20** premarket porn—**62M+ vol tsunami**, rocketing from $1.82 close on $13.9M private placement close (incl warrants) + broader psychedelic pump from Trump PTSD fast-track EO vibes. Brain-boner breakthrough or balance-sheet bukkake?[[2]](https://stockanalysis.com/markets/premarket/gainers/)[[4]](https://www.benzinga.com/premarket)[[5]](https://www.rttnews.com/3640305/enveric-closes-13-9-million-private-placement-to-advance-neuroplastogen-pipeline-stock-up.aspx) **Bull case (psyche shaft supernova)** Fresh $13.9M warchest fuels EB-003 psilocybin depression trials + gov tailwinds = Phase 2 pricktease to $10, low-float squeeze sends it to orbit—degens huffing the hallucination hype! [[6]](https://www.biospace.com/press-releases/enveric-biosciences-announces-closing-of-up-to-13-9-million-private-placement-priced-at-the-market-under-nasdaq-rules)[[7]](https://www.benzinga.com/markets/equities/26/04/51910727/enveric-biosciences-surges-over-90-other-psychedelic-stocks-soar-in-monday-pre-market-whats-going-on) **Bear case (reverse-split rimjob reject)** ATM dilution dump post-1:12 r/s history + cash-burn biotech blackhole = rugpull to $2 turd, short the shroom scam short-circuit! [[8]](https://www.perplexity.ai/finance/ENVB?comparing=ENVB%2CADAPY%2CEDSA%2CIMNN%2CANVS%2CLPCN) **My take, first principles (plastogen prick vs placebo piss)** Strip it: Psychedelics legit for mental reset (FDA nods incoming), $13.9M credible runway but **serial dilution destiny + trial turd odds = degen dice**. Crude cocktease irrelevant. **Rip $3.50-5**, **$7C/$9C** shroom shaft—**P$2** if warrants wank.[[5]](https://www.rttnews.com/3640305/enveric-closes-13-9-million-private-placement-to-advance-neuroplastogen-pipeline-stock-up.aspx) --- ## 2) Clearmind Medicine (CMND): “CMND-100 Cumshot Cure” vs “Trial Tease Tittytwister” **Why it’s loud** **CMND** surging **+57% to ~$1.13** premarket prick—**26M vol vortex**, riding psychedelic wave + recent Phase I safety win on CMND-100 (DEA Schedule I alcohol addiction buster). Sobriety suppository or sobriety scam?[[2]](https://stockanalysis.com/markets/premarket/gainers/)[[4]](https://www.benzinga.com/premarket) **Bull case (addiction assram annihilator)** FDA-approved Phase I/IIa primary endpoint smashed (safety/tolerability) + intranasal delivery deal + Trump mental health rocket = $3+ moonshot, retail rehabbing the rocket ride! [[9]](https://www.msn.com/en-us/money/general/clearmind-shares-surge-as-cmnd-100-achieves-primary-endpoint-in-clinical-trial/ar-AA20RkPD?apiversion=v2&batchservertelemetry=1&domshim=1&noservercache=1&noservertelemetry=1&renderwebcomponents=1&wcseo=1)[[10]](https://finance.yahoo.com/quote/CMND) **Bear case (cash corpse cockblock)** No revenue zombie + prior dilution dumps + biotech bankruptcy bingo = crash to $0.50 delusion, fade the fermented fart! [[11]](https://www.ainvest.com/news/clearmind-medicine-shares-surge-24-62-intraday-cmnd-100-trial-advances-cohort-4-positive-safety-review-2604) **My take, first principles (DEA disruptor dong vs dehydration dud)** Core: CMND-100's ibogaine-like mechanism crushes cravings (real data), sector tailwind hot but **microcap mirage + execution enema = evaporate**. Oil? Snooze. **Long $1-1.50**, **$2C/$3C** trial thrust—**P$0.70** Phase flop.[[12]](https://www.investing.com/news/stock-market-news/clearmind-medicine-stock-surges-on-phase-trial-results-93CH-4612502) --- ## 3) Passage Bio (PASG): “Gene Therapy Gonad Grab” vs “FDA Foreskin Fumble” **Why it’s loud** **PASG** cratering **-23% to ~$9.00** premarket pants-wetter—**73K vol but post-spike slaughter**, tanking on Type C FDA feedback for PBFT02 (FTD-GRN brain disease gene therapy) registrational path. Neuro nerf or negotiation nudge?[[3]](https://stockanalysis.com/markets/premarket/losers/)[[4]](https://www.benzinga.com/premarket) **Bull case (strategic shaft salvage)** FDA outlines *likely* path forward + data shared = undervalued dip-buy to $15, pipeline prick potential intact post-review! [[13]](https://www.rttnews.com/3640281/why-is-passage-bio-stock-falling-in-pre-market.aspx)[[14]](https://www.tipranks.com/news/company-announcements/passage-bio-announces-pbft02-data-and-strategic-review) **Bear case (regulatory rectum rupture)** "Feedback" screams delays/Phase 3 hell + cash guzzle + strategic review whiff = deathspiral to $5 dumpster, short the DNA dickdrop! [[13]](https://www.rttnews.com/3640281/why-is-passage-bio-stock-falling-in-pre-market.aspx) **My take, first principles (AAV gene jab vs approval asshole)** Basics: FTD-GRN orphan moat real (no cures), FDA chat progress but **biotech binary bomb + burn-rate bitchslap = bust bait**. Oil irrelevant. **Dip $7.50-10**, **$14C/$18C** pathway pump—**P$6** trial toilet.[[13]](https://www.rttnews.com/3640281/why-is-passage-bio-stock-falling-in-pre-market.aspx) --- ## Tape-Side Tactics (Shroom Squeeze or FDA Flush?) - **ENVB**: **$3.50-5** dilution dong; **$7C/$9C** funding fuckfest, **P$2** warrant wipeout.[[2]](https://stockanalysis.com/markets/premarket/gainers/) - **CMND**: **$1-1.50** trial teabag; **$2C/$3C** addiction assram, **P$0.70** safety shart.[[2]](https://stockanalysis.com/markets/premarket/gainers/) - **PASG**: **$7.50-10** FDA foreskin; **$14C/$18C** path prick, **P$6** review rug.[[3]](https://stockanalysis.com/markets/premarket/losers/) Futures flatlining, crude creaming—chase the psych pricks or short the gene gag? Ultimate degen drug dice, DYOR, NFA, pure psychedelic precum!